Jerome Boyd-Kirkup is the Co-founder and Chief Scientific Officer of Hummingbird Bioscience, an innovative systems biology enabled biotechnology company. He is responsible for overseeing the development of new technologies and intellectual property, designing experimental strategies for drug discovery, leading the development and testing of novel therapeutics, and overseeing the drug development pipeline. Jerome is a molecular systems biologist by background with extensive experience in both basic and applied translational science at the interface of computational and wet lab biology, and a career research focus of applying systems biology approaches to understanding human disease. Before co-founding Hummingbird Bioscience in 2014, with the aim of applying integrative biology philosophies to drug development, Jerome was an academic at top institutions in the UK and China. He holds a Bachelor's and Master's degree in Biochemistry from Imperial College London and a PhD in Molecular Biology from Cambridge University.